LL-37

Also known as: cathelicidin, hCAP-18 fragment

Immune & Systemic Evidence: Animal

By GLPeptideSciences Editorial Team · How we evaluate evidence · Reviewed by Dr. George S. Watson, MD, Cardiothoracic Surgeon · Updated 2026-06-02

The body's principal cathelicidin antimicrobial peptide, central to host defense and studied for antimicrobial and wound-healing roles — with a notably double-edged biology.

What it is & how it works

What it is

LL-37 is the body’s main cathelicidin — an antimicrobial host-defense peptide that’s part of innate immunity.

How it is thought to work

It can disrupt microbial membranes and also modulates immune signaling and wound healing, which is the basis for therapeutic interest.

The evidence and the caveat

The important nuance: LL-37 is genuinely double-edged. It’s protective in some contexts but has been implicated in driving inflammation and certain disease processes in others. That complexity — plus the lack of established clinical use — is a real argument against casual use.

What it's discussed & studied for

  • Host defense / antimicrobial activity (preclinical)
  • Wound healing and inflammation discussion

Discussion of a use is not a claim that it works or is approved.

Research status

A genuine endogenous host-defense peptide with deep basic-science literature; targeted therapeutic use is investigational and not approved.

Evidence quality

Rich basic biology, but it's a double-edged molecule — implicated in both defense and certain inflammatory/disease processes — and clinical use is unestablished.

Dosing discussion

No approved or validated human protocol exists; community use is extrapolated.

Educational summary of what is discussed in the literature and community — not a dosing recommendation or medical advice.

Safety & harm reduction

Important nuance: LL-37 is genuinely double-edged — protective in some contexts, implicated in inflammatory and disease processes in others. That complexity is a real caution against casual use.

Sourcing literacy

No approved product; research-market material is unverified.

Selected literature

FAQ

Why is LL-37 called 'double-edged'?

It's protective as an antimicrobial in some contexts, but it's also been implicated in driving inflammation and certain disease processes in others — so its biology isn't uniformly beneficial.

Related compounds

Not medical advice. This page is educational and may describe compounds that are not approved for human use. It does not recommend any dose or use. Discussion of "what people report" is anecdotal and unverified. Consult a qualified clinician before making any health decision.